244 related articles for article (PubMed ID: 34837096)
1. The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms.
Pelosi G; Travis WD
Pathologica; 2021 Oct; 113(5):377-387. PubMed ID: 34837096
[TBL] [Abstract][Full Text] [Related]
2. Small Biopsy and Cytology of Pulmonary Neuroendocrine Neoplasms: Brief Overview of Classification, Immunohistochemistry, Molecular Profiles, and World Health Organization Updates.
Sung S; Heymann JJ; Politis MG; Baine MK; Rekhtman N; Saqi A
Adv Anat Pathol; 2022 Nov; 29(6):329-336. PubMed ID: 36053019
[TBL] [Abstract][Full Text] [Related]
3. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.
Marchevsky AM; Hendifar A; Walts AE
Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361
[TBL] [Abstract][Full Text] [Related]
4. Recent updates on grading and classification of neuroendocrine tumors.
Kim JY; Hong SM; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
6. Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms.
Rubino M; Scoazec JY; Pisa E; Faron M; Spaggiari L; Hadoux J; Spada F; Planchard D; Cella CA; Leboulleux S; De Marinis F; Ducreux M; Lamartina L; Baudin E; Fazio N
Lung Cancer; 2020 Oct; 148():149-158. PubMed ID: 32916569
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumor G3 of bronchopulmonary origin and its classification.
Kasajima A; Klöppel G
Pathol Int; 2022 Oct; 72(10):488-495. PubMed ID: 35983917
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
9. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
10. Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors.
Wang HY; Li ZW; Sun W; Yang X; Zhou LX; Huang XZ; Jia L; Lin DM
Chin Med J (Engl); 2019 Mar; 132(5):551-561. PubMed ID: 30807354
[TBL] [Abstract][Full Text] [Related]
11. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
[TBL] [Abstract][Full Text] [Related]
12. Recent advances and current controversies in lung neuroendocrine neoplasms
Metovic J; Bianchi F; Rossi G; Barella M; Sonzogni A; Harari S; Papotti M; Pelosi G
Semin Diagn Pathol; 2021 Sep; 38(5):90-97. PubMed ID: 33810912
[TBL] [Abstract][Full Text] [Related]
13. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
14. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors.
Faggiano A; Mansueto G; Ferolla P; Milone F; del Basso de Caro ML; Lombardi G; Colao A; De Rosa G
J Endocrinol Invest; 2008 Mar; 31(3):216-23. PubMed ID: 18401203
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.
Pelosi G; Rindi G; Travis WD; Papotti M
J Thorac Oncol; 2014 Mar; 9(3):273-84. PubMed ID: 24518085
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of the new WHO classification of pulmonary neuroendocrine tumours.
Younossian AB; Bründler MA; Tötsch M
Swiss Med Wkly; 2002 Oct; 132(37-38):535-40. PubMed ID: 12508138
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
Rouquette Lassalle I
Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
